Patents Assigned to The Coalition for Hemophilia B
  • Methods of production and use of liquid formulations of plasma proteins
    Patent number: 6320029
    Abstract: The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: November 20, 2001
    Assignees: The American National Red Cross, Coalition for Hemophilia B, Inc.
    Inventors: Shirley I. Miekka, William N. Drohan, Thomas R. Jameson, John R. Taylor, Jr., Manish S. Singh
  • Chitin hydrogels, methods of their production and use
    Patent number: 6124273
    Abstract: This invention is directed to the preparation and utilization of supplemented chitin hydrogels, such as chitosan hydrogels. Further provided are biomaterials comprising same. The particular supplement delivered by the chitin hydrogel is selected as a function of its intended use. In one embodiment, this invention provides a composition of matter, comprising a chitin hydrogel or chitin-derived hydrogel, wherein the hydrogel does not inhibit full-thickness skin wound healing.
    Type: Grant
    Filed: October 13, 1997
    Date of Patent: September 26, 2000
    Assignees: Chitogenics, Inc., The American National Red Cross, Coalition for Hemophilia B
    Inventors: William N. Drohan, Martin J. MacPhee, Shirley I. Miekka, Manish S. Singh, Clive Elson, John R. Taylor, Jr.
  • Methods of production and use of liquid formulations of plasma proteins
    Patent number: 5925738
    Abstract: The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.
    Type: Grant
    Filed: November 29, 1996
    Date of Patent: July 20, 1999
    Assignees: The American National Red Cross, The Coalition for Hemophilia B
    Inventors: Shirley I. Miekka, William N. Drohan, Thomas R. Jameson, Manish P. Singh, John R. Taylor, Jr., Martin J. MacPhee
  • Methods of production and use of liquid formulations of plasma proteins
    Patent number: RE38431
    Abstract: The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.
    Type: Grant
    Filed: August 26, 2002
    Date of Patent: February 17, 2004
    Assignees: The American National Red Cross, The Coalition for Hemophilia B
    Inventors: Shirley I. Miekka, William N. Drohan, Thomas R. Jameson, John R. Taylor, Jr., Manish P. Singh, Martin J. MacPhee